References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
Zhengetal(2015)PF-1355,amechanism-basedmyeloperoxidaseinhibitor,preventsimmunecomplexvasculitisandanti-glomerularbasementmembraneglomerulonephritis.J.Pharmacol.Exp.Ther.353288PMID:25698787
Ruggerietal(2015)Discoveryof2-(6-(5-chloro-2-methoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide(PF-06282999):Ahighlyselectivemechanism-basedmyeloperoxidaseinhibitorforthetreatmentofcardiovasculardiseases.J.Med.Chem.588513PMID:26509551
Keywords:PF06281355,supplier,PF06281355,myeloperoxidase,inhibitors,inhibits,selective,orally,bioavailable,vasculitis,Other,Oxygenases/Oxidases,Other,Oxygenases/Oxidases,TocrisBioscience